Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Takuya Tatebe"'
Autor:
Kiwami Kidana, Takuya Tatebe, Kaori Ito, Norikazu Hara, Akiyoshi Kakita, Takashi Saito, Sho Takatori, Yasuyoshi Ouchi, Takeshi Ikeuchi, Mitsuhiro Makino, Takaomi C Saido, Masahiro Akishita, Takeshi Iwatsubo, Yukiko Hori, Taisuke Tomita
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 3, Pp 1-13 (2018)
Abstract Deposition of amyloid‐β (Aβ) as senile plaques is one of the pathological hallmarks in the brains of Alzheimer's disease (AD) patients. In addition, glial activation has been found in AD brains, although the precise pathological role of
Externí odkaz:
https://doaj.org/article/c1813516431b45f9875f39000f699c7a
Autor:
Kazunori Kikuchi, Sho Takatori, Yung Wen Chiu, Miyabishara Yokoyama, Makoto Arita, Taisuke Tomita, Yuki Sudo, Kiwami Kidana, Takuya Tatebe, Yukiko Hori
Publikováno v:
J Neurosci
Alzheimer disease (AD) is characterized by the extensive deposition of amyloid-β peptide (Aβ) in the brain. Brain Aβ level is regulated by a balance between Aβ production and clearance. The clearance rate of Aβ is decreased in the brains of spor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599a3f8017b710798ad62f3b15bb9113
https://doi.org/10.1523/jneurosci.2595-20.2021
https://doi.org/10.1523/jneurosci.2595-20.2021
Publikováno v:
Journal of Cellular Biochemistry. 118:4183-4190
Amyloid-β protein (Aβ) is the main component of senile plaques in the brains of Alzheimer disease (AD) patients. Aβ is proteolytically derived from amyloid-β precursor protein by β- and γ-secretases. Secreted Aβ is then eliminated from the cen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13612bfaa2bac9e9b61e9027d3824601
https://doi.org/10.1002/jcb.26129
https://doi.org/10.1002/jcb.26129
Autor:
Kazunori Kikuchi, Takuya Tatebe, Yuki Sudo, Miyabishara Yokoyama, Kiwami Kidana, Yung Wen Chiu, Sho Takatori, Makoto Arita, Yukiko Hori, Taisuke Tomita
Publikováno v:
Journal of Neuroscience; 7/14/2021, Vol. 41 Issue 28, p6173-6185, 13p
Autor:
Kaori Ito, Maki Hayakawa, Hideo Kubo, Kunimichi Suzuki, Takashi Hirayama, Taisuke Tomita, Mitsuhiro Makino, Takuya Tatebe
Publikováno v:
European journal of pharmacology. 798
Memantine, an uncompetitive glutamatergic N-methyl-D-aspartate (NMDA) receptor antagonist, is widely used as medication for the treatment of Alzheimer's disease (AD). It has been reported that memantine reduces amyloid-β peptide (Aβ) levels in both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1631f5007287440d4813f88b673803
https://pubmed.ncbi.nlm.nih.gov/28167259
https://pubmed.ncbi.nlm.nih.gov/28167259
Autor:
Kiwami Kidana, Taisuke Tomita, Masahiro Akishita, Takuya Tatebe, Yasuyoshi Ouchi, Takeshi Iwatsubo
Publikováno v:
Alzheimer's & Dementia. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c9abbd703daa0418333344a3bf64627
https://doi.org/10.1016/j.jalz.2015.06.594
https://doi.org/10.1016/j.jalz.2015.06.594